Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort
Rodica Pop‐Busui(University of Michigan), J. Jimenez, J. Costello, Silvio E. Inzucchi(Yale University), S. Behringer-Massera, E. Gonzalez Hattery, Aimee Katona(Michigan Medicine), Jill P. Crandall(Albert Einstein College of Medicine), Rajesh Garg(Thumbay Group (United Arab Emirates)), J. Brown-Friday, Jennifer B. Green, H. Estrella, Margaret Tiktin(Louis Stokes Cleveland VA Medical Center), C. Adams, M. Sibymon, L. Holloway, Ruchi Gaba, A. Ideozu, Marc D. McKee(McGill University), Hiba Abou Assi(Duke University), E. Xhori, L. Savoye, Nicole M. Butera(Milken Institute), James E. Boers, David S. Schade(New Mexico Department of Health), J. Lukin, Elsayed Z. Soliman(Cornell University), Tasha Stephanie Raines, Janet B. McGill(Washington University in St. Louis), F. Morehead, Elizabeth Burgess, Samuel P. Rosin(Milken Institute), Sharina D. Person, K. Ballentine-Cargill, A. Balasubramanyam, R. Mungara, Lawrence S. Phillips(Emory University), Heidi Krause‐Steinrauf(Milken Institute), Alyson Ross(University of Maryland, Baltimore), S. Gonzalez de la torre, Christine A. White(Queen's University), M. Maher-Albertelli, S. Tanukonda, Elizabeth R. Seaquist(Diabetes Care Center), C. Gullett, Moo‐Yong Rhee(Dongguk University Ilsan Hospital), Darin E. Olson(Emory University), S. Duran, Sunder Mudaliar(University of California, San Diego), Peter W.F. Wilson(VA Tennessee Valley Healthcare System)
Cited by 1
Related Papers
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
|New England Journal of Medicine|2015|11.9k
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
|Diabetes Care|2012|3.2k